DA Davidson analyst Matt Summerville maintains Volta (NYSE:VLTA) with a Neutral and lowers the price target from $2 to $1.
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5
Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.